[HTML][HTML] Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences

M Yagi, G Bang, T Tougan, NMQ Palacpac, N Arisue… - PLoS …, 2014 - journals.plos.org
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences

M Yagi, G Bang, T Tougan, NMQ Palacpac, N Arisue… - PLoS ONE, 2014 - go.gale.com
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

[PDF][PDF] Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in

M Yagi, G Bang, T Tougan, NMQ Palacpac, N Arisue - 2014 - pdfs.semanticscholar.org
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

[PDF][PDF] Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in

M Yagi, G Bang, T Tougan, NMQ Palacpac, N Arisue - 2014 - researchgate.net
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences

M Yagi, G Bang, T Tougan, NMQ Palacpac… - PloS …, 2014 - pubmed.ncbi.nlm.nih.gov
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

[PDF][PDF] Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in

M Yagi, G Bang, T Tougan, NMQ Palacpac, N Arisue - 2014 - Citeseer
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

[HTML][HTML] Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences.

M Yagi, G Bang, T Tougan, NM Palacpac, N Arisue… - Plos one, 2014 - europepmc.org
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

[引用][C] Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences

M Yagi, G Bang, T Tougan, NMQ Palacpac… - PLoS …, 2014 - ui.adsabs.harvard.edu
Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in
Intrinsically Unstructured N-Terminal Repetitive Sequences - NASA/ADS Now on home …

[HTML][HTML] Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences

M Yagi, G Bang, T Tougan, NMQ Palacpac, N Arisue… - PLoS ONE, 2014 - ncbi.nlm.nih.gov
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …

[PDF][PDF] Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in

M Yagi, G Bang, T Tougan, NMQ Palacpac, N Arisue - 2014 - academia.edu
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of
Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we …